Webcast
Prescient Therapeutics Webcast Replay
In this session Prescient Therapeutics (ASX: PTX) CEO James McDonnell provides investors with a company update.
Xsights Q&A Update
In this session Xsights Co-Founder and CEO Steve Wildisen provides investors with a company update.
Xsights Webcast Replay
In this session Xsights Co-Founder and CEO Steve Wildisen provides investors with a company update.
Copper Bay Resources Q&A Update
In this session Copper Bay Resources Chairman Joseph Webb provides investors with a company update.
Merkle Tree Capital Webcast Replay
In this session Merkle Tree Capital’s CEO Dean Serroni discussed how they managed to become Australia’s #1 performing fund in FY24 in the AFR’s annual fund survey.
Wellnex Life (ASX: WNX) Webcast Replay
In this session Wellnex Life Managing Director Zack Bozinvoski discussed their game-changing deal with $60bn health giant Haleon.
Wellnex Life (ASX: WNX) Q&A Update
In this session Wellnex Life Managing Director Zack Bozinvoski discussed an update on the company’s recent progress, including its financial traction and UK IPO.
Copper Bay Resources Webcast Replay
In this session Copper Bay Resources Chairman Joseph Webb provides investors with a company update.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed Auger sampling results from the NE Fairbanks Project confirming significant soil anomalies, with peak gold values of 568 ppb Au.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed Auger sampling results from the NE Fairbanks Project confirming significant soil anomalies, with peak gold values of 568 ppb Au.
Propell Holdings (ASX: PHL) Webcast Replay
In this session Propell CEO Michael Davidson discussed Propell’s Q1 Financial results, which include the company’s first quarterly cash profit since listing in April 2021.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed how their strongly supported $4.8m placement positions Felix for its near-term antimony production aspiration, aiming for 5,000 tons a year from late 2025.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.